How a price drop in HPV vaccines will save millions of girls and women’s lives
The GAVI Alliance, which introduces life-saving vaccines to developing countries, announced yesterday that the price of the human papillomavirus (HPV) vaccine has seen a drastic cut from US$13 per dose to US$4.50 per dose (the price in high-income countries can be more than US$100 per dose). Tens of millions of women in developing countries can now be protected against cervical cancer through the vaccine, which protects against 70 percent of the strains of cervical cancer.